COMP <GO>
CPIX vs SPRO // OPERATING MARGIN
Cumberland Pharmaceuticals Inc. (NASDAQ) VS. Spero Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CPIX 4
— SPRO 5
▲ OPERATING MARGIN LEADER: SPRO
LAST: $4.69 (+7.82%) • MKT CAP: $65.2M
operating-margins
-6.30%
LAST: $1.06 (-4.50%) • MKT CAP: $64.6M
operating-margins
50.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPIX VS. SPRO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPIX | SPRO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -16.40% | 26.60% | -43.00 | SPRO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 5.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.42% | -19.53% | +26.95 | CPIX | /fcf-yield <GO> |
| Operating Margin ACTIVE | -6.30% | 50.20% | -56.50 | SPRO | /operating-margins <GO> |
| Net Profit Margin | -6.40% | 68.00% | -74.40 | SPRO | /net-margins <GO> |
| Revenue Growth (YoY) | 17.60% | 180.00% | -162.40 | SPRO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.72 | 0.20 | +0.52 | CPIX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | CPIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.3 | 41.2 | -5.94 | SPRO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 6.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $65.2M | $64.6M | $535.9K | CPIX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPIX REV | SPRO REV | CPIX GROSS % | SPRO GROSS % | CPIX FCF | SPRO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.5M | $12.6M | 85.0% | — | $4.8M | -$12.6M |
| FY 2024 | $37.9M | $371.0K | 82.6% | — | -$678.6K | -$23.4M |
| FY 2023 | $39.6M | $933.0K | — | — | $6.1M | -$33.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPIX // BETA —
SPRO // BETA —